Artwork

Contenuto fornito da The PJ Pod and Pharmaceutical Journal. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da The PJ Pod and Pharmaceutical Journal o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !

Spotlight: the story behind the ADHD prescribing surge

11:38
 
Condividi
 

Manage episode 372487966 series 3329558
Contenuto fornito da The PJ Pod and Pharmaceutical Journal. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da The PJ Pod and Pharmaceutical Journal o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
In June 2023, The Pharmaceutical Journal revealed that the number of adults in England prescribed medicines for attention deficit hyperactivity disorder (ADHD) has more than doubled since January 2020. The increase, which was particularly pronounced in females, has been largely fuelled by increasingly frequent opportunities for adults to pinpoint the symptoms of ADHD in themselves, either as a result of COVID-19 lockdowns or owing to growing awareness of famous faces recounting their own ADHD diagnoses. While the added demand is already seeing patients wait years for treatment from over-extended NHS services for the condition, experts say ADHD is still vastly underdiagnosed. In this episode of The PJ Pod, executive editor Carolyn Wickware and senior features editor Dawn Connelly take a closer look at the prescribing data and talk about what this increase in diagnoses means for patients and the NHS going forward.
  continue reading

43 episodi

Artwork
iconCondividi
 
Manage episode 372487966 series 3329558
Contenuto fornito da The PJ Pod and Pharmaceutical Journal. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da The PJ Pod and Pharmaceutical Journal o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
In June 2023, The Pharmaceutical Journal revealed that the number of adults in England prescribed medicines for attention deficit hyperactivity disorder (ADHD) has more than doubled since January 2020. The increase, which was particularly pronounced in females, has been largely fuelled by increasingly frequent opportunities for adults to pinpoint the symptoms of ADHD in themselves, either as a result of COVID-19 lockdowns or owing to growing awareness of famous faces recounting their own ADHD diagnoses. While the added demand is already seeing patients wait years for treatment from over-extended NHS services for the condition, experts say ADHD is still vastly underdiagnosed. In this episode of The PJ Pod, executive editor Carolyn Wickware and senior features editor Dawn Connelly take a closer look at the prescribing data and talk about what this increase in diagnoses means for patients and the NHS going forward.
  continue reading

43 episodi

Tutti gli episodi

×
 
Loading …

Benvenuto su Player FM!

Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.

 

Guida rapida